China property stocks surge to highest levels in a year as stimulus rally continues

China property stocks surge to highest levels in a year as stimulus rally continues


SHENZHEN, CHINA – MARCH 09: View of high commercial and residential buildings on March 9, 2016 in Shenzhen, China. General economic slowdown continues in China while the property price and stock bubble faces risk. (Photo by Zhong Zhi/Getty Images)

Zhong Zhi | Getty Images News | Getty Images

Shares of most Hong Kong-listed Chinese property stocks surged to their highest levels in over a year, as China’s stimulus rally continues.

The real estate sector was the biggest gainer in the Hang Seng Index, with Longfor Group Holdings being the top mover, adding over 25%.

Shares of other real estate developers also saw significant gains. Shimao Group skyrocketed over 87% while Kaisa Group jumped 40.48%, both notching their highest prices in more than a year.  

Similarly, China Overseas Land & Investment climbed 12.31% to hit its highest since last September. China Vanke rose 39.6% to its highest since August 2023.

Hang Lung Properties and China Resources Land gained 10.01% and 10.82% respectively. 

The wider Hang Seng Index added 6%, while the Hang Seng Mainland Properties Index surged over 14%. Mainland Chinese markets are closed for the Golden Week holiday.

The continued drag from the property sector will leave a sizable shortfall in demand behind, keeping growth below target.

Over the weekend, major cities in mainland China introduced easing measures to enhance homebuyer confidence, following a series of policy stimulus initiatives from the central bank last Tuesday.

Guangzhou’s city government announced that all restrictions on home purchases would be removed starting Monday. Shanghai’s reduction of the required tax-paying period also came into effect on Tuesday. Shenzhen has also relaxed purchasing restrictions, allowing buyers to purchase one more apartment in select districts. 

While these measures will help stabilize the property market, lifting prices and reviving demand will be a tall order, Morgan Stanley wrote in a note published Wednesday.

“The continued drag from the property sector will leave a sizable shortfall in demand behind, keeping growth below target,” the investment bank’s Asia-Pacific economists wrote.

Real estate used to account for over 25% of China’s GDP, but it has faced a prolonged decline since 2020 following Beijing’s crackdown on the sector’s excessive debt.

Chinese officials have ramped up support to alleviate financial pressures on households and stabilize the embattled real estate market. However, these previous initiatives have not resulted in significant turnarounds.



Source

Federal Aviation Administration approves SpaceX Starship 5 flight
World

Federal Aviation Administration approves SpaceX Starship 5 flight

The Federal Aviation Administration approved a license on Saturday for the launch of SpaceX’s Starship 5 set for as early as Sunday. Reuters first reported earlier this week the faster than expected timetable after the FAA in September had said it did not expect a determination on a license before late November. The FAA said […]

Read More
Former Scottish First Minister Alex Salmond, who sought Scotland’s independence, has died at age 69
World

Former Scottish First Minister Alex Salmond, who sought Scotland’s independence, has died at age 69

Jeff J Mitchell, Getty Images Alex Salmond, the former first minister of Scotland who for decades championed Scotland’s independence from the U.K., has died. He was 69. U.K. Prime Minister Keir Starmer paid tribute to Salmond, calling him a “monumental figure” of both Scottish and British politics. “He leaves behind a lasting legacy,” Starmer said. […]

Read More
U.S. FDA to reconsider decision barring compounded versions of Lilly weight loss drug
World

U.S. FDA to reconsider decision barring compounded versions of Lilly weight loss drug

Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders from selling their own versions of Eli Lilly’s blockbuster weight loss and diabetes drugs. The agency said […]

Read More